Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator  by Takei, Yoshio et al.
Identi¢cation of novel adrenomedullin in mammals: a potent
cardiovascular and renal regulator
Yoshio Takeia;, Koji Inouea, Maho Ogoshia, Tetsushi Kawaharab, Hideo Bannaic,
Satoru Miyanoc
aLaboratory of Physiology, Department of Marine Bioscience, Ocean Research Institute, University of Tokyo, 1-15-1 Minamidai, Nakano-ku,
Tokyo 164-8639, Japan
bPharmaceutical Research Center Discovery Research III, Mochida Pharmaceutical Co. Ltd., Gotenba, Shizuoka 412-8524, Japan
cHuman Genome Center, Institute of Medical Science, University of Tokyo, Minato-ku, Tokyo 108-8639, Japan
Received 25 October 2003; revised 13 November 2003; accepted 15 November 2003
First published online 28 November 2003
Edited by Horst Feldmann
Abstract We have identi¢ed cDNA encoding a new member of
the adrenomedullin (AM) family, AM2, for the ¢rst time in
mammals (mouse, rat and human). The predicted precursor car-
ried mature AM2 in the C-terminus, which had an intramolec-
ular ring formed by an S^S bond and a possibly amidated
C-terminus. Phylogenetic analyses clustered AM2 and AM
into two distinct but closely related groups. Similarity of
exon^intron structure and synteny of neighboring genes showed
that mammalian AM2 is an ortholog of pu¡er¢sh AM2 and a
paralog of mammalian AM. AM2 mRNA was expressed in
submaxillary gland, kidney, stomach, ovary, lymphoid tissues
and pancreas of mice, but not in adrenal and testis. Intravenous
injection of synthetic mature AM2 decreased arterial pressure
more potently than AM, and induced antidiuresis and antina-
triuresis in mice. These results show that at least two peptides,
AM and AM2, comprise an adrenomedullin family in mammals,
and that AM2 may play pivotal roles in cardiovascular and
body £uid regulation.
. 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Calcitonin gene-related peptide (CGRP), adrenomedullin
(AM), amylin (islet amyloid polypeptide), and the recently
discovered calcitonin receptor-stimulating peptide are struc-
turally related to each other and form a hormone family
named CGRP superfamily [1]. However, their biological func-
tions are much diversi¢ed among the peptides. AM is a new
regulatory peptide discovered in 1993 [2]. Subsequent studies
have shown that AM is expressed in various tissues and ex-
hibits many functions including cardiovascular and £uid reg-
ulation [3], regulation of growth and di¡erentiation, and other
hormone secretions [4,5]. AM is also implicated in various
disease states such as cardiovascular and renal disorders, sep-
sis, cancer and diabetes [6,7]. This spectrum of functions is
thought to be achieved by interaction with multiple receptors
and their association with multiple receptor activity-modifying
proteins (RAMPs) and receptor component proteins (RCPs)
[8^10]. However, there is a possibility that the diverse func-
tions of AM are due to multiple closely related peptides that
share their receptors and associated proteins.
Recently, we have isolated cDNAs encoding ¢ve AM-like
peptides from the pu¡er¢sh, Takifugu rubripes, and named
them AM1^5 [11]. They are apparently derived from a com-
mon ancestral gene, and phylogenetic analyses grouped them
into a cluster di¡erent from that of CGRP genes. Therefore,
we suggested the possibility that AM forms an independent
family of paralogous peptides that are di¡erent from CGRP
and amylin in vertebrates including mammals. Among the
members of the AM family identi¢ed in teleost ¢shes, AM1
is an ortholog of mammalian AM because linkage analysis
showed that the same genes clustered in the vicinity of the
AM/AM1 gene of human, mouse and pu¡er¢sh. Pu¡er¢sh
AM1, 4, and 5 genes were expressed in various tissues includ-
ing the interrenal (adrenal homolog) as mammalian AM.
However, AM2 and 3 genes were expressed most abundantly
in the brain. Together with the similarity of overall sequences
and exon^intron structures, pu¡er¢sh AMs were divided
roughly into two groups, AM1/4/5 and AM2/3 [11]. However,
members of the AM2/3 group have not yet been identi¢ed in
mammals.
In the present study, we initially attempted to identify mam-
malian AM2/3 genes in silico using the sequence information
of pu¡er¢sh peptides. Then the cDNAs of candidate peptides
were actually cloned from mouse, rat and human tissues, and
the identity to AM2 was determined by their overall similar-
ity, exon^intron structure, synteny of neighboring genes, and
pattern of tissue distribution of transcripts. Finally, the puta-
tive mature AM2 peptide was chemically synthesized, and its
cardiovascular and renal actions were examined in vivo using
urethane-anesthetized mice and compared with those of AM.
2. Materials and methods
2.1. Molecular biological studies
2.1.1. RNA extraction. Two male mice (40.5 and 45.0 g) and two
female mice (35.8 and 32.6 g) of the ICR strain, and a male rat of the
Wistar strain (245 g) were purchased from a commercial source. After
anesthesia with diethylether, animals were pithed, and the brain, pi-
tuitary, submaxillary gland, heart, thymus, lung, liver, spleen, pan-
creas, stomach, small intestine, large intestine, mesentery, adrenal
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glands, vertebra, and gonads were dissected out and immediately fro-
zen in liquid nitrogen. The uterus and mammary gland were also
collected from female mice. Total RNA was extracted from each
tissue using Isogen (Nippon Gene).
2.1.2. cDNA cloning. Initially, we screened the EST and genome
sequence ¢les released by the National Center for Biotechnology In-
formation (NCBI), ftp://ftp.ncbi.nlm.nih.gov/blast/db/, to obtain ho-
mologs of the pu¡er¢sh AM family based on the amino acid sequen-
ces of mature peptides. For this purpose, we have developed a
program, named BiogrepX (http://biocaml.org:8080/Vbannai/bg/),
which allows searching for Perl-style regular expressions of protein
sequences, from various protein and nucleotide sequence databases.
In the case of nucleotide sequence databases, BiogrepX searches for
regular expression on all six translation frames. The use of regular
expressions enables searching for more speci¢cally conserved sequen-
ces, which may be highly degenerate overall and would be overlooked
by more general methods such as BLAST [12]. The screening detected
AM-like sequences in the mouse, rat and human databases, which
were distinct from AM of each species but apparently homologs of
pu¡er¢sh AM2. Therefore, we named them mouse, rat and human
AM2 (see below). The primers for cDNA cloning were designed based
on these sequences (Table 1).
Double-strand cDNA pool was prepared by the SMART system
(Clontech) using 2 Wg total RNA of the mouse or rat kidney. The
coding regions of mouse and rat AM2 cDNAs were cloned by the
3P-rapid ampli¢cation of cDNA ends method using the CDSIII/3P-
PCR primer of the kit and speci¢c primers mAM2-F1 or rAM2-F1
for mouse and rat, respectively (Table 1). The polymerase chain re-
action (PCR) was done for 35 cycles at the annealing temperature of
60‡C under the conditions reported previously [11]. Human kidney
¢rst strand cDNA was purchased from BD Biosciences. Human
AM2 was ampli¢ed by PCR with primers in the 3P and 5P non-coding
regions (Table 1). After an initial PCR reaction with primers AM2-a
and AM2-f for 25 cycles at the annealing temperature of 55‡C, the
signal was further ampli¢ed by nested PCR with primers AM2-b and
AM2-e for 30 cycles at 70‡C. After electrophoresis, the products were
puri¢ed, subcloned into pT7 Blue (Novagen), and sequenced.
2.1.3. Phylogenetic analysis. Precursor sequences of mouse, rat,
human and/or pu¡er¢sh AM2, AM/AM1, CGRP and amylin were
aligned using the CLUSTAL W alignment program at http://www.
ddbj.nig.ac.jp/E-mail/clustalw-j.html/. A phylogenetic tree was con-
structed using the neighbor-joining method.
2.1.4. Tissue distribution of transcripts. The tissue distribution of
AM2 and AM gene transcripts was analyzed in two male and two
female mice by reverse transcription (RT)-PCR. One microgram of
total RNA from each tissue was reverse-transcribed as described pre-
viously [11]. The primers used for PCR were mAM2-F1 and mAM2-
R1 for AM2 and mAM1-F2 and mAM1-R for AM (Table 1).
As an internal control, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) transcripts were ampli¢ed using the primers GAPDH-S3
and GAPDH-A3. The PCR reaction was performed for 35 cycles for
AM2 and AM and 28 cycles for GAPDH under the condition re-
ported previously [11]. Ampli¢ed products were electrophoresed on
1.2% agarose gels and visualized by ethidium bromide staining.
2.1.5. Exon^intron structure. The exon^intron structure of mouse,
human and pu¡er¢sh AM2 genes was determined by comparing the
cDNAs with genomic DNA sequences, which were obtained from the
website at http://www.ncbi.nih.gov/Genomes/index.html.
2.1.6. Synteny of neighboring genes. To determine the relationship
among mammalian and pu¡er¢sh AM2s, we surveyed neighboring
genes on mouse chromosome 15, human chromosome 22 and pu¡er-
¢sh genome sca¡old M000040 using the websites at http://www.ncbi.
nlm.nih.gov/mapview/ and http://fugu.hgmp.mrc.ac.uk/fugu-bin/clo-
nesearch/. In addition, loci around the AM gene on human chromo-
some 11 were also surveyed to determine the relationship between
human AM and AM2 genes.
2.2. Physiological studies
All physiological experiments were conducted in line with the
Guidelines for the Care and Use of Laboratory Animals approved
by the Committee for Animal Experiments of the University of To-
kyo.
2.2.1. Surgery. Eight male mice of the ICR strain at 6^8 weeks of
age (35.1 P 0.52 g) were anesthetized by an intramuscular injection of
urethane at 2.25 g/kg and tracheotomy was performed. The carotid
artery and external jugular vein were cannulated with PE 10 tubes
(Clay Adams), the tips of which were tapered after heating and pull-
ing. The urinary bladder was cannulated with a funnel-like catheter
made from a PE 10 tube.
2.2.2. Experimental protocol. The arterial catheter was used for
monitoring blood pressure and heart rate in a polygraph (NEC
San-ei), and the venous catheter for continuous infusion of Ringer
solution (NaCl 130, KCl 5, CaCl2 5.3, NaHCO3 2 in mM) at 10 Wl/
min. Urine £ow rate was monitored by a drop counter, and urine was
collected every 20 min by a fraction collector. Urine Naþ concentra-
tion was measured by an atomic absorption spectrophotometer
(Z5300, Hitachi).
Predicted mature human AM2 with amidated C-terminus (see be-
low) was synthesized by the Peptide Institute. Human AM was pur-
chased from the Peptide Institute. Each peptide was dissolved in 0.9%
NaCl containing 0.01% Triton X-100 and injected through a venous
catheter at the dose of 0.1, 1 or 10 nmol/kg.
2.2.3. Statistical analyses. The vasodepressor e¡ects of AM2 and
AM were compared by analysis of variance (ANOVA) followed by
Tukey’s test. Changes in urine volume and urinary Naþ excretion
(volumeUconcentration) were compared every 20 min after AM or
AM2 injection with the pre-injection values by repeated measures
ANOVA. Signi¢cance was set at P6 0.05. All data are expressed as
meansPS.E.M.
3. Results and discussion
3.1. Molecular biological studies
We have cloned AM2-like cDNAs from three mammalian
species and named them mouse, rat and human AM2 (Fig.
1a). The overall identity of predicted precursor sequences in-
cluding the signal peptide was 90% between mouse and rat,
which is much higher than that of AM (79%) [5]. The inferred
mature sequence was even more conserved and only one of 48
amino acids including C-terminal glycine di¡ered between
mouse and rat (Fig. 1b). The mammalian AM2 possessed
structures common to the AM family including the presence
of an intramolecular ring of six amino acid residues £anked
by an S^S bond and a potential amidation signal at the C-ter-
minus. The highly conserved sequence of AM2 was particu-
larly obvious across di¡erent classes of vertebrates; sequence
identity was 71% between mouse and pu¡er¢sh, which was
much higher than that of AM/AM1 (50%). The sequence
identity between AM2 and AM was rather low; the identity
was 33% in the case of mice (Fig. 1b).
The phylogenetic tree depicted based on the precursor se-
quence showed that AM2 and AM/AM1 of mammals and
pu¡er¢sh were clustered into the respective groups (Fig. 2).
A close relationship between mammalian and pu¡er¢sh AM2
was further supported by the similar termination pattern of
Table 1
List of primers used for cloning and RT-PCR analyses
Name Sequence
AM2-a GGACGCCCGTGCCCAGCTTGCCA
AM2-b CCATGGCCCGGATCCCGACG
AM2-e TCAGCCATAGCTGTGGGGGCT
AM2-f GCAGCTCTGGACGGGGGCACAGCA
GAPDH-A3 ATCGAAGGTGGAAGAGTGGGAGT
GAPDH-S3 TACATGGTCTACATGTTCCAGTATGA
mAM1-F GTATCAGACCATCGCCACAG
mAM1-F2 GGCCAGATACTCCTTCGCAGTTC
mAM1-R GCCCGACTGTTCAATGCTGT
mAM2-F1 CAAACTGGTTTTCCGCTGG
mAM2-R1 TCATAGGTTTAGGGTATCCAAAGCC
rAM2-F1 CAAACTAGTTTTCCGCTGAACC
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the precursor C-terminus and exon^intron architecture of
their genes. The C-terminal glycine of AM2 was followed by
a stop codon (Fig. 1a) and AM2/3 genes were interrupted by
only one intron in the coding region (Fig. 3a). AM/AM1
precursors are followed by four consecutive arginine residues
that are removed after processing [13], and AM/AM1 genes
are interrupted by two introns in the coding region [11]. Com-
parative genomic analyses concluded that mammalian AM2 is
the ortholog of pu¡er¢sh AM2; synteny of AM genes and at
least three neighboring genes was conserved among mouse,
human and pu¡er¢sh (Fig. 3b).
Tissue distribution of mRNA showed that AM2 is ex-
pressed in various tissues of mice; high expression was de-
tected in the submaxillary gland, kidney, stomach and mesen-
tery, followed by the pituitary, lung, pancreas, intestines,
spleen and thymus (Fig. 4). This expression pattern is quite
di¡erent from that of pu¡er¢sh AM2, which is expressed al-
most exclusively in the brain [11]. It is possible that mamma-
lian AM2 is expressed only in a restricted region of the brain,
which may have masked its expression in the whole brain. The
brisk expression in the pituitary suggests its paracrine/auto-
crine role in pituitary hormone secretion as suggested for AM
in mammals [14^16]. In addition, AM2 was expressed in the
ovary but not in the testis, indicating some speci¢c role for the
female reproductive system as suggested for AM [17]. AM2
appears to be expressed more than AM in the immune system
[4].
Phylogenetic analyses showed that AM/AM1 and AM2 are
more closely related to each other than to CGRP and amylin
(Fig. 2). Therefore, AM/AM1 and AM2 appear to belong to
the same hormone family independent of CGRP and amylin
Fig. 1. Amino acid sequences of AMs. a: Precursor sequences of mouse, rat and human AM2 deduced from the cloned cDNA. Sequences iden-
tical to mouse AM2 are reversed. Putative signal sequence is underlined [33]. Putative mature peptide is boxed. Accession numbers: mouse
AM2, AB121035; rat AM2, AB101236; human AM2, AB121034. Asterisks represent stop codons. b: Comparison of mature AM2 and AM/
AM1 sequences from mammals and pu¡er¢sh. Amino acid residues identical to the mouse peptide are reversed in each group. Brackets show
disul¢de bonds.
Fig. 2. Phylogenetic tree of mouse (m), rat (r), human (h) and puf-
fer¢sh (Tr) AM2, AM, CGRP, and/or amylin depicted by the neigh-
bor-joining method. Precursor sequences were used for the analysis.
Bootstrap values after 1000 trials are indicated on the tree. Acces-
sion numbers: mouse AM, NM_009627; CGRP, AF330212; amylin,
NM_010491; rat AM, NM_012715; CGRP, M11597; amylin,
NM_012586; human AM, NM_001124; CGRP, X02330; amylin,
NM_000415; pu¡er¢sh AM1, AB120295; AM2, AB120296; CGRP,
AJ309015.
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as suggested in the pu¡er¢sh [11]. A closer relationship of
AM2 and AM/AM1 genes was further supported by the pres-
ence of paralogous genes on the same chromosome; MAP-
K8IP2, ALDRL6, PARVB and SOX10 co-localized with the
AM2 gene on human chromosome 22, while MAPK8IP1,
ALDRL3, PARVA and SOX6 co-localized with the AM
gene on human chromosome 11.
3.2. Physiological studies
The average arterial pressure and heart rate of urethane-
anesthetized mice were 66.0P 2.8 mm Hg and 579P 31 beats/
min (n=8), respectively. Synthetic human AM2 exhibited po-
tent and long-lasting hypotensive actions in the mouse (Fig. 5)
as reported for AM in several species of mammals [2,18^20].
The AM2 e¡ect was dose-dependent and was more potent
than human AM (Fig. 6a). Since the amino acid sequences
of AM2 and AM are highly conserved between mouse and
human (Fig. 1b), human peptides may have full activities in
the mouse. The hypotensive e¡ect continued for 166.0P 16.9
min (n=4) at 10 nmol/kg, which is much longer than that of
atrial natriuretic peptide (ANP) [21]. This may be due to the
longer half-life of AM (22.0 min) than ANP (1.5 min) [14].
AM2 also exhibited a chronotropic e¡ect in the mouse (Fig. 5)
as AM does in the rabbit [18].
Since the mice originate from a dry area in Central Asia
[22], they urinated scarcely and it took more than 4 h to
obtain constant and signi¢cant urine £ow after Ringer infu-
sion at 10 Wl/min. The average urine £ow rate and Naþ ex-
cretion rate after equilibrium was 135P 18 Wl/h and 8.13P 0.91
Wmol/h (n=8), respectively. A bolus injection of AM2 transi-
ently inhibited urine £ow in the mouse (Fig. 5). Since urine
Naþ concentration decreased after AM2 injection, the antina-
triuretic e¡ect continued longer than the antidiuretic e¡ect
(Fig. 6b). The transient decrease in urine £ow rate also oc-
curred after AM injection, but to a much lesser extent com-
pared with AM2 (Fig. 6b). Since diuretic and natriuretic ef-
fects of AM have been reported in other mammalian species
[23^26], the inhibitory e¡ect may be speci¢c to the mice. How-
ever, it is to be noted that AM2 and AM induced diuresis and
delayed natriuresis in over-hydrated mice to which Ringer was
infused at 30 Wl/min (data not shown). In no case did diuresis
and natriuresis occur in mice infused at 10 Wl/min.
Fig. 3. Structure of AM2 genes. a: Exon^intron structures of
mouse, human and pu¡er¢sh AM2 and 3 genes. Exons are shown
as boxes. Mature AM sequences are in black, and coding regions
are shadowed. Blank boxes indicate untranslated sequences. b: Con-
served synteny of genes around the AM2 gene among mouse, hu-
man and pu¡er¢sh. Arrows indicate the direction of each gene.
A, BC024879 for mouse and KIAA0685 for human; B, ALDRL6;
C, AI451006 for mouse and BC002942 for human. A and C have
di¡erent names in mouse and human but are orthologs.
Fig. 4. Expression of AM2 and AM genes in various tissues of male
and female mice examined by RT-PCR. GAPDH is used as an in-
ternal control. Similar results were obtained in two males or two fe-
males.
Fig. 5. An example of changes in arterial pressure (AP), heart rate
(HR) and urine £ow rate after injection of AM2 at 10 nmol/kg in
urethane-anesthetized mouse. Each spike represents 15 Wl of urine
dropped from a bladder catheter. Arrows show the point of injec-
tion.
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After the initial discovery of AM from human pheochro-
mocytoma [2], extensive studies have shown that AM is a
multifunctional peptide that plays pivotal roles not only in
cardiovascular and £uid homeostasis but also in growth/devel-
opment, carcinogenesis and others [3^5]. The present identi¢-
cation of AM2 in mammals indicates that some of the multi-
ple AM functions may be shared by the paralogous AM2
through the same receptors. To elucidate this issue, it needs
to be determined whether AM2 actions are mediated by its
own speci¢c receptors or shared by calcitonin receptor-like
receptor and related proteins such as RAMPs and RCPs
[27^29].
The current study identi¢ed a novel hormone in mammals
based on its identi¢cation in a teleost ¢sh. Similar discoveries
of ¢sh hormones in mammals have already been reported for
several hormones such as melanin-concentrating hormone,
stanniocalcin, urotensin and others, and these new hormones
have been shown to play important roles in mammals [30^32].
With the availability of new tools and techniques for molec-
ular biological discovery, such contributions of comparative
studies to general (mammalian) endocrinology will further
increase in the future.
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